HCPCS Code C1899: Lead, pacemaker/defibrillator combination implantable

Key Takeaways

HCPCS code C1899 describes a Lead, pacemaker/cardioverter-defibrillator combination implantable – a single lead that performs both pacing and defibrillation functions

C1899 is an HCPCS Level II C-code used exclusively by hospital outpatient departments billing under the Outpatient Prospective Payment System (OPPS)

Specific dollar amounts for the 2026 fee schedule must be verified against CMS Addendum B, as rates change with each annual OPPS Final Rule update

Pabau’s claims management software helps hospital billing teams track OPPS device codes, flag documentation gaps, and reduce claim denials for high-cost implantable devices

Hospital outpatient coding teams frequently encounter claim issues with implantable cardiac device leads – and a major source of errors is selecting the wrong code when a lead serves dual pacing and defibrillation functions. Claims management software built for outpatient settings can flag these mismatches before submission, but coders still need a solid grasp of what HCPCS code C1899 covers and when it applies. This reference guide covers the code description, code attributes, 2026 fee schedule context, OPPS billing guidelines, Medicare coverage rules, and the comparison codes most likely to cause confusion.

HCPCS Code C1899: description and device covered

HCPCS code C1899 describes a Lead, pacemaker/cardioverter-defibrillator combination implantable. Its short description, used in claim processing systems, is “Lead, pmkr/aicd combination.” The code falls under HCPCS Level II, the alphanumeric code set maintained by the Centers for Medicare and Medicaid Services (CMS) for supplies, devices, and services not covered by CPT codes.

C-prefix codes within HCPCS Level II are temporary codes assigned specifically for new technology and high-cost devices used in the hospital outpatient setting. C1899 belongs to the Assorted Devices, Implants, and Systems range (C1760-C2615), per the AAPC HCPCS code range classification.

The combination designation in C1899 is clinically significant. Some patients with advanced cardiac conditions require a device capable of both pacing (correcting a heart that beats too slowly) and defibrillation (delivering a shock to reset a dangerously abnormal rhythm). A single lead that covers both functions is distinct from a dedicated pacemaker lead (C1895) or a dedicated defibrillator lead (C1896), so the correct code choice depends on what the implanted lead actually does.

C1899 code attributes and OPPS status indicator

Every HCPCS C-code carries a set of attributes that determine how Medicare pays for it under OPPS. The status indicator (SI) assigned to C1899 is the single most important field for hospital outpatient billing staff to review in the CMS OPPS Addendum B each year, because it dictates the payment methodology. According to CMS’s HCPCS overview, C-codes are maintained by CMS and updated through the annual OPPS Final Rule.

Hospital coding staff relying on outdated Addendum B files are the most common source of status indicator errors. CMS publishes the OPPS Final Rule each November with APC and SI updates effective January 1 of the following year; quarterly updates can also affect individual codes between annual cycles. Always pull the current Addendum B directly from CMS before billing.

2026 fee schedule and Medicare reimbursement for HCPCS code C1899

Medicare reimbursement for C1899 is determined under OPPS through the Ambulatory Payment Classification (APC) group assigned to the code. The APC rate is not a flat per-unit price for the lead itself; rather, it represents the composite payment for the outpatient encounter grouped to that APC. Because OPPS rates change annually with the Final Rule, the specific 2026 reimbursement amount for HCPCS code C1899 must be pulled from the current CMS HCPCS code list or CMS Addendum B.

Third-party fee schedule tools can provide general rate ranges for reference, but they should not be used as the authoritative source for claim submission. The following table outlines the payment factors relevant to billing teams.

For commercial payers, reimbursement for implantable cardiac device codes like C1899 is typically governed by the hospital’s individual contract rather than OPPS. Billing teams should consult the payer-specific fee schedule and verify whether prior authorization is required before the implant procedure is performed. Good EHR integration between the facility’s implant tracking system and its billing platform reduces the lag between implant date and claim submission for these high-value device codes.

Billing guidelines for HCPCS C1899

C1899 is restricted to hospital outpatient department (HOD) claims submitted under OPPS. Physician offices, ambulatory surgery centers (ASCs), and inpatient settings do not use HCPCS C-codes for this device category. The following billing rules apply specifically to hospital outpatient coders working with Medicare claims.

• Provider type: Hospital outpatient departments only. C-codes by definition are not valid outside OPPS-participating facilities.
• Bill type: Typically reported on a UB-04 claim form (837I transaction) with the appropriate revenue code and HCPCS code C1899.
• Units: Report one unit per lead implanted. If two leads are placed during the same encounter, report two units of C1899 (assuming both are combination leads).
• Device credits: When a hospital receives a manufacturer credit for a replaced device, CMS no-pay and reduced-payment rules may apply. Review the Medicare Claims Processing Manual, Chapter 4, for the current no-pay threshold for high-cost cardiac device codes.
• Modifier use: Confirm with current CMS guidance whether any modifiers are required or prohibited with C1899. Modifier requirements can change with annual OPPS updates.
• Bundling: The status indicator on C1899 determines whether the device cost is packaged into the procedural APC or paid separately. A status indicator of “N” means the payment is packaged; confirm the current SI in Addendum B.

Documentation supporting the claim should clearly identify the implanted lead as a combination pacemaker/cardioverter-defibrillator lead. Operative reports, implant stickers (device identifier labels), and device tracking logs are all supporting documents that Medicare auditors look for when reviewing C-code claims.

Paperless documentation practices that capture implant data electronically make this audit trail significantly easier to maintain.

Hospital billing teams managing high volumes of cardiac device cases benefit from structured workflows that link the operative report directly to the charge capture event. Practice management software features designed for multi-provider outpatient facilities can automate some of this linkage, reducing the risk of a device being implanted and not billed within the claim submission window.

For the broader context of HIPAA compliance for clinic software when handling sensitive cardiac procedure records, ensure your facility’s billing platform meets the required data security standards.

Reduce claim denials on high-cost device codes

Pabau's claims management tools help hospital billing teams track OPPS device code submissions, flag documentation gaps before claims go out, and maintain a clean audit trail for high-value implantable cardiac procedures.

Book a demo

Medicare coverage and payer policy for HCPCS code C1899

Medicare covers implantable cardiac leads, including combination pacemaker/defibrillator leads, when the implant is medically necessary for a covered indication. Coverage for HCPCS code C1899 is subject to Local Coverage Determinations (LCDs) and National Coverage Determinations (NCDs) that specify the clinical criteria a patient must meet before a pacemaker or ICD is implanted.

Billing teams should confirm that the documented indication in the medical record aligns with the applicable LCD or NCD before submitting the claim.

The following coverage considerations apply to most Medicare claims for C1899.

• Medical necessity: The physician’s documentation must support the patient’s diagnosis and the decision to implant a combination lead. Lack of documented medical necessity is the primary reason for Medicare denial on implantable cardiac device claims.
• LCD review: Check whether the Medicare Administrative Contractor (MAC) serving your jurisdiction has issued an LCD covering cardiac rhythm management devices. MACs such as Noridian and CGS publish specific cardiac device coding articles that supplement CMS national guidance.
• ABN requirements: If there is reason to believe Medicare may not cover the procedure for a specific patient, an Advance Beneficiary Notice of Noncoverage (ABN) should be issued before the service is performed.
• Secondary payers: For patients with Medicare as secondary payer, the primary insurer’s coverage determination and Explanation of Benefits (EOB) are required before the Medicare claim is processed.

Commercial payers do not follow OPPS methodology and are not bound by CMS coverage determinations. Each commercial plan’s coverage policy for implantable cardiac leads should be reviewed prior to the procedure, particularly for prior authorization requirements.

The NLM’s HCPCS Level II API provides a free programmatic lookup resource for verifying code attributes when integrating C-code data into payer verification workflows.

Understanding the pacemaker/cardioverter-defibrillator combination lead

The device described by C1899 is a single transvenous lead engineered to deliver both cardiac pacing impulses and high-energy defibrillation shocks. This combination capability matters for coding because it eliminates the need to report two separate leads when a single implanted component serves both functions.

Clinically, combination leads are used in patients who receive a cardiac resynchronization therapy defibrillator (CRT-D) or certain types of implantable cardioverter-defibrillator (ICD) systems that also provide backup pacing.

The lead connects the pulse generator to the heart tissue, sensing intrinsic cardiac activity and delivering therapy as needed. For hospital coders, the critical distinction is not the device generator but the type of lead that was actually implanted and documented in the operative report.

When reviewing procedure documentation, look for these indicators that C1899 is the appropriate code:

• The operative report describes a single lead placed in the right ventricle (or another chamber) with both pacing and shocking electrode coils
• The implant sticker or device identifier confirms a “combination” or “integrated” lead model
• The physician documents implantation of an ICD or CRT-D system with a single combination lead rather than separate pacing and sensing leads

Accurate identification of the lead type at the point of charge capture prevents the common error of billing a pacemaker-only lead code (such as C1895) or a defibrillator-only lead code (such as C1896) when a combination lead was actually used.

Facilities that track implantable device inventory through their medical forms and documentation systems can cross-reference device lot numbers with manufacturer specifications to confirm the lead category before coding.

C1899 vs related HCPCS codes: C1895, C1896, and others

The most frequent coding error involving C1899 is selecting an adjacent cardiac lead code when the device type actually warrants C1899. The table below compares the most commonly confused codes in this range, based on the ICD lead HCPCS code group and adjacent C-codes for cardiac devices.

The distinction between C1899 and C1896 comes up frequently because both involve defibrillator leads. C1896 covers a defibrillator lead that does not provide pacing capability, while C1899 covers a lead that does both.

When a coder is uncertain, the implant sticker affixed to the operative report contains the manufacturer’s product number, which can be cross-referenced against the manufacturer’s product catalog to confirm whether the lead is a combination type.

For related diagnostic code context, hospital coders often pair cardiac device codes with the appropriate ICD-10 procedure code for the implant encounter. For a reference on how ICD-10 diagnostic code reference structures work in a clinical documentation context, Pabau’s diagnostic code resources provide additional coding guidance relevant to outpatient billing workflows.

How OPPS and APC assignment affect C1899 payment

OPPS pays hospital outpatient claims through a grouping methodology that assigns each reported HCPCS code to an Ambulatory Payment Classification (APC). The APC determines the base payment rate for the encounter. For device codes like HCPCS code C1899, the status indicator assigned in Addendum B is the key variable.

Status indicator “N” means the device cost is packaged into the procedural APC and not paid separately. Status indicator “J1,” “J2,” or “S” signals that the code is paid under a comprehensive or separately payable APC. The payment mechanics work as follows:

• Packaged (SI = N): The hospital does not receive a separate line-item payment for C1899. The cost of the lead is expected to be covered within the APC rate for the implant procedure code reported on the same claim.
• Separately payable (SI = J1, J2, or S): C1899 generates its own APC payment in addition to the procedural APC. This is more common for high-cost items that CMS has determined are not adequately covered by the composite or procedural rate alone.
• Pass-through payment (SI = H): A temporary status applied to new technology devices for a limited period, providing a payment in addition to the APC rate while CMS gathers cost data. C-codes frequently hold this status when first assigned.

Hospital charge master teams should audit the SI for C1899 each year when the OPPS Final Rule is published and again after each quarterly update. A mismatch between the charge master SI assumption and the actual CMS-published SI causes systematic under- or over-billing across every cardiac implant case using that code.

The Medicare Informatics HCPCS tables provide a useful cross-reference for verifying SI assignments across HCPCS code ranges.

For hospital outpatient billing teams managing multiple high-cost implantable device lines, a structured charge capture process that links the specific HCPCS code to its current APC and SI reduces both underpayment exposure and overpayment risk on RAC audits.

Connecting procedure code fee schedule management across the organization’s billing infrastructure is one practical way to keep these code attributes current. Additionally, coders who need to understand how CPT codes for specialized procedures interact with HCPCS device codes in the same encounter can review crosswalk resources to avoid duplicate billing.

Code history and annual updates for HCPCS code C1899

HCPCS C-codes for implantable devices are updated through the annual CMS OPPS Final Rule cycle, with the possibility of mid-year revisions via CMS quarterly HCPCS updates. C1899 is listed as active for 2026 Medicare billing on third-party HCPCS reference platforms, though coders should verify the effective date and active status against the CMS HCPCS quarterly update files before relying on any single source.

Hospital billing compliance programs should maintain a scheduled HCPCS code review process that incorporates all four quarterly update windows. Designating a coding compliance lead to review the CMS HCPCS release notes each quarter ensures that charge master updates for high-cost device codes like C1899 are applied before claims are submitted with incorrect code status.

Facilities that integrate their charge master with a robust EMR software platform can often automate portions of this update cycle, reducing manual review burden on the coding team.

Conclusion

Hospital outpatient coding errors on HCPCS code C1899 most often stem from three causes: selecting an adjacent code (C1895, C1896) without confirming the lead type, using an outdated status indicator assumption in the charge master, and insufficient documentation of the implanted device’s combination function.

Resolving all three requires both accurate code knowledge and a billing infrastructure that supports current code attributes and clean documentation workflows.

Pabau’s claims management software supports hospital billing teams with structured charge capture, documentation gap flagging, and audit-ready record keeping that keeps OPPS device code submissions clean from the first submission. To see how Pabau handles high-cost implantable device billing workflows in a live setting, book a demo with our team.

Continue your research

Need to understand how billing codes interact with compliance documentation? HIPAA compliance for medical offices covers the documentation and data security requirements that support clean claims for sensitive cardiac procedure records.

Looking for guidance on procedure code fee schedules across payer types? CPT coding reference for outpatient procedures provides a structured overview of how procedure codes and fee schedules interact across different billing settings.

Want to reduce manual charge capture errors on implantable device claims? Digital forms for clinical documentation help capture implant data at the point of procedure, creating an electronic audit trail that supports HCPCS device code submissions.

Frequently Asked Questions